These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 16229768)

  • 1. Simulated anthrax attacks and syndromic surveillance.
    Nordin JD; Goodman MJ; Kulldorff M; Ritzwoller DP; Abrams AM; Kleinman K; Levitt MJ; Donahue J; Platt R
    Emerg Infect Dis; 2005 Sep; 11(9):1394-8. PubMed ID: 16229768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An evaluation model for syndromic surveillance: assessing the performance of a temporal algorithm.
    Buckeridge DL; Switzer P; Owens D; Siegrist D; Pavlin J; Musen M
    MMWR Suppl; 2005 Aug; 54():109-15. PubMed ID: 16177701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Bayesian approach for estimating bioterror attacks from patient data.
    Ray J; Marzouk YM; Najm HN
    Stat Med; 2011 Jan; 30(2):101-26. PubMed ID: 20963771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syndromic surveillance for influenzalike illness in ambulatory care network.
    Miller B; Kassenborg H; Dunsmuir W; Griffith J; Hadidi M; Nordin JD; Danila R
    Emerg Infect Dis; 2004 Oct; 10(10):1806-11. PubMed ID: 15504267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergency department visits for concern regarding anthrax--New Jersey, 2001.
    Allegra PC; Cochrane D; Dunn E; Milano P; Rothman J; Allegra J
    MMWR Suppl; 2005 Aug; 54():163-7. PubMed ID: 16177709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surveillance for anthrax cases associated with contaminated letters, New Jersey, Delaware, and Pennsylvania, 2001.
    Tan CG; Sandhu HS; Crawford DC; Redd SC; Beach MJ; Buehler JW; Bresnitz EA; Pinner RW; Bell BP; ;
    Emerg Infect Dis; 2002 Oct; 8(10):1073-7. PubMed ID: 12396918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling the incubation period of inhalational anthrax.
    Wilkening DA
    Med Decis Making; 2008; 28(4):593-605. PubMed ID: 18556642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bichat guidelines for the clinical management of anthrax and bioterrorism-related anthrax.
    Bossi P; Tegnell A; Baka A; Van Loock F; Hendriks J; Werner A; Maidhof H; Gouvras G;
    Euro Surveill; 2004 Dec; 9(12):E3-4. PubMed ID: 15677848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing surveillance using sensitivity, specificity and timeliness.
    Kleinman KP; Abrams AM
    Stat Methods Med Res; 2006 Oct; 15(5):445-64. PubMed ID: 17089948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of syndromic surveillance systems--design of an epidemic simulation model.
    Buckeridge DL; Burkom H; Moore A; Pavlin J; Cutchis P; Hogan W
    MMWR Suppl; 2004 Sep; 53():137-43. PubMed ID: 15714643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gram-positive rod surveillance for early anthrax detection.
    Begier EM; Barrett NL; Mshar PA; Johnson DG; Hadler JL;
    Emerg Infect Dis; 2005 Sep; 11(9):1483-6. PubMed ID: 16229790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Gram-positive rod surveillance for early anthrax detection.
    Mlynarski D; Rabatsky-Ehr T; Petit S; Purviance K; Mshar PA; Begier EM; Johnson DG; Hadler JL;
    Epidemiol Infect; 2009 Nov; 137(11):1623-30. PubMed ID: 19397835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laboratory response to anthrax bioterrorism, New York City, 2001.
    Heller MB; Bunning ML; France ME; Niemeyer DM; Peruski L; Naimi T; Talboy PM; Murray PH; Pietz HW; Kornblum J; Oleszko W; Beatrice ST; ;
    Emerg Infect Dis; 2002 Oct; 8(10):1096-102. PubMed ID: 12396923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syndromic surveillance and bioterrorism-related epidemics.
    Buehler JW; Berkelman RL; Hartley DM; Peters CJ
    Emerg Infect Dis; 2003 Oct; 9(10):1197-204. PubMed ID: 14609452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating the joint disease outbreak-detection time when an automated biosurveillance system is augmenting traditional clinical case finding.
    Shen Y; Adamou C; Dowling JN; Cooper GF
    J Biomed Inform; 2008 Apr; 41(2):224-31. PubMed ID: 18194876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Responding to a bioterrorism attack-one scenario: part 2.
    Clarke TL; Rotarius T; Liberman A; Cattani J; Nieves K; Sumner J; Palaniappan R
    Health Care Manag (Frederick); 2008; 27(4):298-306. PubMed ID: 19011411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioterrorism-related anthrax: international response by the Centers for Disease Control and Prevention.
    Polyak CS; Macy JT; Irizarry-De La Cruz M; Lai JE; McAuliffe JF; Popovic T; Pillai SP; Mintz ED;
    Emerg Infect Dis; 2002 Oct; 8(10):1056-9. PubMed ID: 12396915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The anthrax attacks 10 years later.
    Bush LM; Perez MT
    Ann Intern Med; 2012 Jan; 156(1 Pt 1):41-4. PubMed ID: 21969275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating detection of an inhalational anthrax outbreak.
    Buckeridge DL; Owens DK; Switzer P; Frank J; Musen MA
    Emerg Infect Dis; 2006 Dec; 12(12):1942-9. PubMed ID: 17326949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bio-ALIRT biosurveillance detection algorithm evaluation.
    Siegrist D; Pavlin J
    MMWR Suppl; 2004 Sep; 53():152-8. PubMed ID: 15714645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.